Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$100.76 - $138.36 $1.78 Million - $2.45 Million
-17,697 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$132.37 - $176.78 $2.34 Million - $3.13 Million
17,697 New
17,697 $2.37 Million

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $926M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Crawford Lake Capital Management, LLC Portfolio

Follow Crawford Lake Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crawford Lake Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crawford Lake Capital Management, LLC with notifications on news.